Aayushi Pratap / Chemical & Engineering News:
Excelsior Sciences, which aims to use AI and robots for small-molecule drug discovery and development, raised a $70M Series A from Khosla Ventures and others — Excelsior Sciences cofounders say the company will make new molecules using robots and artificial intelligence
